the lesion revealed an abundance of extracellular matrices that were homogeneous, amorphous, eosinophilic, and collagen-like and that contained spindle-shaped cells ( Fig.  3) . No mature collagen fibrils were present. The spindleshaped cells that were thought to be fibroblasts displayed an immunonegative response to S100 protein. On the basis of these typical pathological findings, it was thought that the patient could be suffering from JHF.
For mutational analysis, DNA was extracted from peripheral lymphocytes. The 17 exons of the CMG-2 gene were amplified using primers flanking the exons and the intronexon boundaries. Conformation-sensitive gel electrophoresis was used to screen CMG-2. Genomic DNA demonstrating mobility shift on CSGE was bidirectionally sequenced using the BigDyeTerminator Cycle Sequencing Kit and a 3100 automated sequencer (ABI; Perkin Elmer, Norwalk, CT); 7,8 however, no mutations were identified in the CMG-2 gene.
Postoperative Course. The patient was well 2 years after the operation. On his most recent visit, he was free of any complaints, and was not suffering from gingival hyperplasia, joint contractures, or any new skull or skin lesions.
Discussion
First described by Murray in 1873 as molluscum fibrosum, JHF is characterized by the production and deposition of an unidentified hyaline material in the skin and other organs. 21 To date, fewer than 60 case reports have been published, 3 and Kitano 12 coined the name currently in use in 1976. Siblings have been affected, and parental consanguinity was noted in several cases; 13 therefore, an autosomal-recessive mode of inheritance is suggested. 13 The disease particularly involves the skin, gingiva, joints, distal phalanges, long bones, and skull. The skin lesions can be polymorphous, and they can consist of multiple large tumors. 13 Gingival hypertrophy is a common finding and can be severe enough to interfere with feeding. Joint contractures often develop, causing flexion contractures of the fingers, elbows, hips, and knees. 13 A variety of bone lesions have been identified on radiographs and include osteolysis of the distal phalanges, skull, and long bones. 6, 13, 19 These skeletal lesions have histological features similar to those of skin lesions, and may or may not be associated with overlying skin tumors. 15 Infantile systemic hyalinosis has similar clinical and histopathological characteristics, but those affected die in early childhood. 8, 13 Although it has been a matter of controversy whether JHF and ISH are different entities or part of the same disease spectrum, it has recently been demonstrated by two different groups of researchers that both disorders are allelic and are caused by mutations in the gene encoding CMG-2. 1, 4, 21 Some authors believe that the lesions will regress with age. 15, 19 In the generally accepted opinion, however, the prognosis for patients is not good, and most of them are left with deformities and joint contractures. Some patients are followed up for long periods, such as 8, 15, 19, or even 30 years. 15, 22 Gilabarte, et al., 8 reviewed 33 cases in the literature along with their case and reported diagnostic criteria for JHF as follows: major criteria are cutaneous lesions (including nodules, tumors, and plaques) and gingival enlargement; minor criteria are joint contractures, osteolytic lesions and/or cortical erosions, and family history for JHF. They also stated that histological confirmation is necessary.
The patient presented with a solitary calvarial lytic lesion only, with no other skin, gingival, or bone and joint involvements. The parents were nonconsanguineous healthy adults. The patient underwent an operation with the suspicion that the lesion was Langerhans cell histiocytoma; however, histological features were typical of JHF. These include an abundance of homogeneous amorphous ground substance in which spindle-shaped tumor cells with elliptical nuclei are embedded. 23 The bone, muscle, and joint involvement is characterized by interstitial deposition of amorphous eosinophilic material similar to that observed in the skin. 4 Our case also featured an abundance of homogeneous amorphous eosinophilic extracellular matrices that contained spindle-shaped cells.
The differential diagnosis of such a lesion includes localized infantile myofibromatosis, cranial fasciitis, and neurofibroma. In investigating myofibromatosis, microscopically one finds fascicles containing myofibroblastic cells, primitive areas composed of smaller rounded cells, and necrotic areas. In cranial fasciitis, a loose myxoid area is populated by nonpleomorphic myofibroblasts loosely arranged with a tissue-culture appearance. The background stroma shows variable myxoid change. 5, 18 The presented tumor was different from these two lesions, having no myofibroblastic cells, no necrotic areas, and different stroma. Neurofibroma is characterized by hyperchromatic tumor cells with serpentine nucleolus in a fibrillary eosinophilic stroma, but these cells display an immunopositive response to S100 protein. 20 In the presented tumor, however, cells were immunonegative to Ϫ100.
Expression variability is not unusual in JHF, and partial disease expression has been described. 13, 15 De Rosa, et al., 3 posited two clinical variants of JHF: 1) the localized form, characterized by limited cutaneous involvement only and by small, very slow-growing skin tumors; and 2) the diffuse form, in which cutaneous involvement is wide, with large and rapidly growing tumors. If it is true that two distinct forms of JHF exist, then it appears that in belonging to the "localized form," our patient may represent an extreme example of clinical heterogeneity associated with JHF. No new skin or locomotor lesions appeared in this patient 2 years after the operation; however, localized disease can in time evolve into the diffuse form. In a patient in whom JHF was diagnosed at 29 years of age, widespread locomotor involvement had occurred 5 years after removal of a scalp tumor when he was 9 years of age. 11 Therefore, regular follow up of a patient with JHF is necessary.
Several pathogenetic mechanisms for JHF have been proposed. According to recent research, the formation of the hyaline ground substance seems to be caused by a focal mesenchymal cell proliferation followed by an abnormal production and accumulation of glycosaminoglycans and glycoproteins. 10 A defect in collagen synthesis has been demonstrated. 14 Some investigators have suggested that the abnormal collagen fibers result from an underlying defect in glycosaminoglycan formation. 17 Characterization of the gene and the protein it encodes now provides fresh data that are expected to allow a better understanding of the pathogenesis of JHF. Capillary morphogenesis protein-2 was originally identified as a gene upregulated in endothelial cells induced to undergo capillary formation in three-dimensional collagen matrices. 1 The lack of mutations in the CMG-2 gene in the present case also deserves attention. On a theoretical ground, it is possible that JHF is associated with genetic heterogeneity and that other genes, especially those interacting with CMG-2, may also be responsible for the disease. Another possible explanation could be the somatic mutation of the CMG-2 gene, which can only be demonstrated in the DNA extracted from the biopsy specimen. Unfortunately, we were not able to perform mutational analysis of DNA isolated from the biopsy sample. In the absence of additional clinical findings other than the calvarial lytic lesion and a demonstrable mutation of the CMG-2 gene, we suggest that the present case represents an atypical and localized form of JHF.
Treatment of JHF consists of excision of the tumors, mainly for cosmetic reasons, but recurrences are common. 13 If surgical treatment is not performed promptly, the nodules can continue to grow and may become very large. 3 In the patient presented here, surgery was performed because of the misdiagnosis of Langerhans cell histiocytoma.
Conclusions
Although JHF is a rare and peculiar systemic disease, the solitary calvarial lesion in the present case suggests that it may be associated with clinical and genetic heterogeneity. Further molecular and clinical studies are necessary, however, to document whether a distinct, localized form of JHF exists. We also suggest that JHF be remembered in the differential diagnosis of a solitary calvarial osteolytic lesion.
